ANDA 215338, held by Amneal. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 215338 (Vancomycin Hydrochloride), held by Amneal, was first approved by FDA on Jun 23, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 23, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vancomycin HydrochlorideEQ 250MG BASE/5ML ยท for solution;oral | Vancomycin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters